Solorank.ai
Login

Cached score snapshot

US.PODD · Insulet Corporation

110分制 37.8/110；5D動能v2 3/50；排序分 40.8/160 · Incomplete inputs

Back to ranking Open volume snapshot
Ranking score 40.8/160
Main score 37.8/110
5D momentum v2 3/50
Rank #482
Setup grade F 15.4

Score breakdown

避免

Elevated twelvedata

Score and price trend

F 15.4 Elevated risk

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 06-17 07-31 09-14 10-05 10-23 $122.38$151.50$180.61 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.34 · anchors 120 +2.50% -0.55% / +5.38% 70% 1.3% Actual outcome pending · 0 / 3 bars observed
30D observation +10.57% +4.59% / +17.49% 85% 7.5% Actual outcome pending · 0 / 30 bars observed
Historical projection 10D n=160 +0.97% -1.63% / +4.78% 62.5% 5.6% Actual outcome pending · 0 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-06-17 → 2026-10-23 · 120 archived points · 1 Improving turn signal · 5 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 40.8
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 37.8/110 (避免)
5D momentum v2 3/50 (弱)
Score with momentum v2 40.8/160 (低排序)
Risk level Elevated

Audit trace

Full calculation detail

Calculation detail · 8 sections

Incomplete score

此 snapshot 已計出評分，但以下輸入仍不完整；缺失維度以 0 分處理，請留意 audit 明细。

  • VIX_MISSING: VIX market context is required for market environment scoring

Market inputs

Bar count 60
ma20 144.404
ma50 152.6988
close 131.96
prevClose 134.68
avgVolume20 1712293
volumeRatio 1.02
changePercent -2.02

Metrics snapshot

close 131.96
volume 1747855
changePercent -2.02

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 37.8/110
Main rating 避免
5D momentum v2 3/50
Score with momentum v2 40.8/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.8/5 · 良好
Dimension score 3.8/5
Dimension grade 良好

Sub-items

pbPoints 0.2
pePoints 0.4
epsPoints 0
roePoints 0.75
debtPoints 0.5
marginPoints 0.4
turnoverUsdM 230.647
volumePoints 0.5
revenuePoints 0.75
dividendPoints 0
marketCapPoints 0.3

資金流 — 5.2/20 · 較差
Dimension score 5.2/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 0.8
obvPoints 0.8
vwapPoints 0.8

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.PODD
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 5.6/15 · 較差
Dimension score 5.6/15
Dimension grade 較差

Sub-items

vix

score 0

details

source twelvedata+fred
missing true
vixClose n/a

trend

score 2.8

details

qqq

ma20 715.668
ma50 710.4064
name QQQ
close 714.88
points 1.4

spy

ma20 766.879
ma50 758.6164
name SPY
close 764.29
points 1.4
source twelvedata+fred
atrPct 3.8456
atrPoints 2
cciPoints 0.8
vixPoints 0
marketTrendPoints 2.8

催化劑 — 2/20 · 較差
Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 5.7/10 · 較差
Dimension score 5.7/10
Dimension grade 較差

Sub-items

position

score 1.1

details

atrPct 3.8456
turnoverUsdM 230.647
liquidityPoints 0.4
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.PODD
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 121.8108

strength_details

ma_score 1
atr_score 1
rsi_score 2.5
macd_score 1
volume_score 2
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 7.7
take_profit_price 141.6018
target_multiplier 1.9
technical_strength 1.5
take_profit_percent 7.3
positionPoints 1.1
stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 7.6911
diversificationPoints 2

技術信號 — 11.5/30 · 較差
Dimension score 11.5/30
Dimension grade 較差

Sub-items

bbPoints 1.8
adxPoints 3
sarPoints 1.2
vcpPoints 1.8
macdPoints 0.8

vcpPayload

vcp_pass false
vcp_score 1.8
vcp_reason 波幅收縮(34.6%→13.2%)；跌縮量(近10日3日)；Ready=N；Confirm=N

vcp_metrics

up_days 3
vol_ref 1863216.6667
down_days 6
vcp_ready false
above_ma50 false
avg_vol_10 1979190
avg_vol_20 1693325
avg_vol_30 1863216.6667
range_pct_10 0.1318
range_pct_20 0.1596
range_pct_30 0.3464
up_expand_ok false
lookback_used 59
near_20d_high false
contraction_ok true
down_shrink_ok true
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 1.0622
dist_to_20d_high 0.1496
down_shrink_days 3
breakout_level_20d 155.17
vcp_breakout_confirm false
contraction_ratio_10_30 0.3804
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.5
rsiKdjPoints 0.8
volumeWeight 2
maCrossPoints 0
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 1.2

情緒分析 — 4/10 · 較差
Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 1
positiveHits 3
sentimentScoreRaw 0.6

sentimentData

raw {"id":142029607,"url":"https://finnhub.io/api/news?id=a15ec301a31b6e7f4e0f08b004cb23dd648e2301a3e8fcc370222e3088d36e4e","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"PODD","summary":"Insulet Corporation (PODD) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 2:15 PM EDTCompany ParticipantsAshley McEvoy - CEO, President...","category":"company","datetime":1788974829,"headline":"Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"}, {"id":141951350,"url":"https://finnhub.io/api/news?id=28b3b3e06fe81b01c5eb52c9782efef57078576f0a8aeac8ecb4fccc662f866c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March lows as resilient economic data, strong corporate earnings, and continued AI investment improved investor sentiment despite inflation concerns, delayed rate cuts, and […]","category":"company","datetime":1788872410,"headline":"Artisan Sold Insulet (PODD) Due to Competition Concerns"}, {"id":141438505,"url":"https://finnhub.io/api/news?id=9d42b3600ff93ffb09a10f692f5824b90d0eba371bb0c419e622ec2cff3806a8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1788535813,"headline":"Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?"}, {"id":141406956,"url":"https://finnhub.io/api/news?id=1d043a22deff0d3cc4726665b3ef514a32b8c375daaaf25689b7011a08251649","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.","category":"company","datetime":1788482358,"headline":"Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks"}, {"id":141390062,"url":"https://finnhub.io/api/news?id=dccc316b29670c6de9edc2dcd11d9f9e8839c98c0ef6f270bdc86a8578def3be","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Insulet stock has fallen sharply over the past year, yet both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market multiples currently point to the shares trading below what those models suggest, while the broader valuation score still comes through as a mixed signal rather than a clear bargain. The share price is down 57.0% over the past year, which puts recent trading well below where many investors may have entered the stock. Future adoption of Insulet's...","category":"company","datetime":1788379903,"headline":"Insulet (PODD) Stock May Be 40% Undervalued On Fair Value Grounds"}, {"id":141379770,"url":"https://finnhub.io/api/news?id=973d3d9b65571134e6c4bde0f5b68fd5efb7f9aea2c841b60c77ad81e05f554f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Insulet (PODD) is back in focus after ongoing reminders about a securities class action lawsuit tied to alleged issues in its manufacturing controls and recent voluntary Medical Device Corrections disclosed in March and May 2026. At a share price of US$148.38, Insulet has seen short term resilience with a 7 day share price return of 3.73%. However, the 30 day share price return is down 10.26% and the 1 year total shareholder return has declined 56.98%, which points to fading momentum as...","category":"company","datetime":1788361765,"headline":"Is Insulet (PODD) Undervalued On Lawsuit And Device Correction Risks?"}, {"id":141328903,"url":"https://finnhub.io/api/news?id=5723a8874efaeaed2fe3e923c6fabea9394b7aba4751e2b8b3d56ac1bfe82abc","image":"https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp","source":"ChartMill","related":"PODD","summary":"Insulet Corp (PODD) fits the affordable growth screen: strong EPS and revenue growth, reasonable valuation, and overall solid profitability.","category":"company","datetime":1787824858,"headline":"Insulet (NASDAQ:PODD): Growth at a Reasonable Valuation"}, {"id":141364468,"url":"https://finnhub.io/api/news?id=f5f23b1f38e5783222ccb643de6fbd02540422cf97dae9f0047cc2cd7a0d4460","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Insulet's Q2 beat and stronger margins contrast with a 2026 growth reset, putting U.S. Type 2 retention at the center of its outlook.","category":"company","datetime":1787668380,"headline":"Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?"}
raw_source {"id":142029607,"url":"https://finnhub.io/api/news?id=a15ec301a31b6e7f4e0f08b004cb23dd648e2301a3e8fcc370222e3088d36e4e","image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","source":"SeekingAlpha","related":"PODD","summary":"Insulet Corporation (PODD) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 2:15 PM EDTCompany ParticipantsAshley McEvoy - CEO, President...","category":"company","datetime":1788974829,"headline":"Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"}, {"id":141951349,"url":"https://finnhub.io/api/news?id=a5e82ee6c3cf64f27ddd444f5e9a43dba1000c87210d229028d562806bcf0ee3","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"PODD's Omnipod 5 adoption, product expansion and raised international growth outlook support its growth prospects despite competitive and cost pressures.","category":"company","datetime":1788873840,"headline":"Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?"}, {"id":141951350,"url":"https://finnhub.io/api/news?id=28b3b3e06fe81b01c5eb52c9782efef57078576f0a8aeac8ecb4fccc662f866c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March lows as resilient economic data, strong corporate earnings, and continued AI investment improved investor sentiment despite inflation concerns, delayed rate cuts, and […]","category":"company","datetime":1788872410,"headline":"Artisan Sold Insulet (PODD) Due to Competition Concerns"}, {"id":141438505,"url":"https://finnhub.io/api/news?id=9d42b3600ff93ffb09a10f692f5824b90d0eba371bb0c419e622ec2cff3806a8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.","category":"company","datetime":1788535813,"headline":"Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?"}, {"id":141434501,"url":"https://finnhub.io/api/news?id=f73103254be6a86525c1740bf09c42233cf10fdf09a0565d6c188026dd47ff8d","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1340690121/image_1340690121.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"PODD","summary":"During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products.","category":"company","datetime":1788520200,"headline":"Baron SMID Cap ETF Q2 2026 Portfolio Activity"}, {"id":141406956,"url":"https://finnhub.io/api/news?id=1d043a22deff0d3cc4726665b3ef514a32b8c375daaaf25689b7011a08251649","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.","category":"company","datetime":1788482358,"headline":"Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks"}, {"id":141390062,"url":"https://finnhub.io/api/news?id=dccc316b29670c6de9edc2dcd11d9f9e8839c98c0ef6f270bdc86a8578def3be","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Insulet stock has fallen sharply over the past year, yet both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market multiples currently point to the shares trading below what those models suggest, while the broader valuation score still comes through as a mixed signal rather than a clear bargain. The share price is down 57.0% over the past year, which puts recent trading well below where many investors may have entered the stock. Future adoption of Insulet's...","category":"company","datetime":1788379903,"headline":"Insulet (PODD) Stock May Be 40% Undervalued On Fair Value Grounds"}, {"id":141379770,"url":"https://finnhub.io/api/news?id=973d3d9b65571134e6c4bde0f5b68fd5efb7f9aea2c841b60c77ad81e05f554f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Insulet (PODD) is back in focus after ongoing reminders about a securities class action lawsuit tied to alleged issues in its manufacturing controls and recent voluntary Medical Device Corrections disclosed in March and May 2026. At a share price of US$148.38, Insulet has seen short term resilience with a 7 day share price return of 3.73%. However, the 30 day share price return is down 10.26% and the 1 year total shareholder return has declined 56.98%, which points to fading momentum as...","category":"company","datetime":1788361765,"headline":"Is Insulet (PODD) Undervalued On Lawsuit And Device Correction Risks?"}, {"id":141370033,"url":"https://finnhub.io/api/news?id=381f81ad45688e1542cb11cc990ba4fa7c875e6d273eb58c2defbcb634c09e82","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"The diabetes tech firm is preparing for the launch of new devices, including a tubeless insulin pump and a fully closed loop automated insulin delivery system.","category":"company","datetime":1788266868,"headline":"MiniMed submits new patch pump for FDA clearance"}, {"id":141355523,"url":"https://finnhub.io/api/news?id=66cd2776f7c30a964722094b09bd6a18e34943fce0381882ba1635f3c58fe405","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"PODD","summary":"Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.","category":"company","datetime":1788194101,"headline":"Uncover the latest developments among S&P500 stocks in today's session."}, {"id":141344225,"url":"https://finnhub.io/api/news?id=ce6367c3e91ba904d0bcc3077660dfca1e037faf6438e4d3385f6a8c0b54f734","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2163867989/image_2163867989.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"PODD","summary":"Insulet Corporation delivered strong Q2 2026 results with 23.5% revenue growth, strong customer additions, and solid profitability. Click for more on PODD.","category":"company","datetime":1788003000,"headline":"Insulet Corporation: Strong Growth Meets A New Execution Problem"}, {"id":141328903,"url":"https://finnhub.io/api/news?id=5723a8874efaeaed2fe3e923c6fabea9394b7aba4751e2b8b3d56ac1bfe82abc","image":"https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp","source":"ChartMill","related":"PODD","summary":"Insulet Corp (PODD) fits the affordable growth screen: strong EPS and revenue growth, reasonable valuation, and overall solid profitability.","category":"company","datetime":1787824858,"headline":"Insulet (NASDAQ:PODD): Growth at a Reasonable Valuation"}, {"id":141337053,"url":"https://finnhub.io/api/news?id=c3c6d6b76c788113efddd79bd3fc98e7ad59df9c98e3fbb9fd6a878afa997360","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Bloomberg Indices announced the following changes to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, September 10, 2026, to coincide with the September reconstitution of the index. The B500 contains 500 of the most highly capitalized US companies, weighted by float-adjusted market capitalization, representing more than USD 60 trillion in aggregate market capitalization.","category":"company","datetime":1787779980,"headline":"Bloomberg 500 (B500) Index Adds Ten Securities Following September Reconstitution"}, {"id":141365784,"url":"https://finnhub.io/api/news?id=63fa02f189a6a151a9d95ebf513ea0ac8c3a117aa4e14aba4714ca4ff37a5f41","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Opportunities include AI-enabled adherence platforms, connected inhalers, injectors and smart packaging, telehealth and home-care integration, chronic disease support, and pharmacy-led services in underserved and Asia-Pacific markets. Medication Adherence Market Medication Adherence Market Dublin, Aug. 26, 2026 (GLOBE NEWSWIRE) -- The \"Medication Adherence Market by Type of Solution, Type of Product, Route of Administration, Therapeutic Area, End-user, and Key Geographical Regions- Trends and Fo","category":"company","datetime":1787749200,"headline":"Medication Adherence Global Market Report 2026-2035: Profiles Medtronic, Roche, Insulet, Ypsomed, and 13 Other Key Players"}, {"id":141365785,"url":"https://finnhub.io/api/news?id=66070406c6a83f5814842e5f8f6ba4b97144f78ffea528efad6ddc579aaa15db","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"ACTON, Mass., August 26, 2026--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the Wells Fargo 21st Annual Healthcare Conference in Boston on Wednesday, September 9, 2026, at 2:15 p.m. (Eastern Time).","category":"company","datetime":1787745600,"headline":"Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference"}, {"id":141323906,"url":"https://finnhub.io/api/news?id=d51cae098bce93cf8ef7e16d66ce95996ebfd0ed923bffa3c37acb05dd0b23af","image":"https://cdn.benzinga.com/files/images/story/2026/08/26/Abbott-Laboratories.jpg?width=2048&height=1536","source":"Benzinga","related":"PODD","summary":"The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.","category":"company","datetime":1787736992,"headline":"FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking"}, {"id":141365786,"url":"https://finnhub.io/api/news?id=6a5c27160372ef6f66df58924ebb451e6aa8dd85e3ec70146b96cddadab250ef","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Insulet has considerably underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.","category":"company","datetime":1787670731,"headline":"Is Wall Street Bullish or Bearish on Insulet Stock?"}, {"id":141364468,"url":"https://finnhub.io/api/news?id=f5f23b1f38e5783222ccb643de6fbd02540422cf97dae9f0047cc2cd7a0d4460","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Insulet's Q2 beat and stronger margins contrast with a 2026 growth reset, putting U.S. Type 2 retention at the center of its outlook.","category":"company","datetime":1787668380,"headline":"Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?"}, {"id":141314075,"url":"https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"PODD","summary":"Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.","category":"company","datetime":1787613074,"headline":"The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"}, {"id":141365788,"url":"https://finnhub.io/api/news?id=ce0ca9ce7f2580191193eec24899a44fe7beb18d5f4486a7b8029f443eac4d1c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"McEvoy invested $162,217 at a weighted average price of $147.47, bringing total beneficial ownership to 23,735 shares valued at $3.52 million.","category":"company","datetime":1787581981,"headline":"Insulet CEO Ashley McEvoy Buys $160,000 in Shares After 55% Stock Decline. What Is This Telling Investors?"}, {"id":141308288,"url":"https://finnhub.io/api/news?id=e9386091a547b5c5ac5664a5b9868042b9c5f651b4bfd68eef3b900e2c40acb2","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"PODD","summary":"Get insights into the top gainers and losers in the S&P500 index of Monday's pre-market session.","category":"company","datetime":1787574900,"headline":"These S&P500 stocks are moving in today's pre-market session"}, {"id":141312732,"url":"https://finnhub.io/api/news?id=7d6c65ba66aba3343a9dc3597fee531404625af1f1cbb6ea5cb0fd4ea70557b6","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/insider_trade_3.jpg?width=2048&height=1536","source":"Benzinga","related":"PODD","summary":"Disclosed in the latest SEC filing, a significant insider purchase on August 24, involves Ashley McEvoy, President and CEO at Insulet (NASDAQ:PODD).\nWhat Happened: McEvoy made a significant move by purchasing 1,100","category":"company","datetime":1787569233,"headline":"President and CEO Of Insulet Purchased $162K In Stock"}, {"id":141286149,"url":"https://finnhub.io/api/news?id=d71a5e7c6aef10990f071b8cdbd16a963deff81815e0488e9ba2690edc71ef1f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals. This trend will likely pick up with new regulatory leadership, but a few mid-sized businesses will continue prospering by anchoring themselves in unique market segments.","category":"company","datetime":1787319347,"headline":"3 Mid-Cap Stocks with Competitive Advantages"}, {"id":141247855,"url":"https://finnhub.io/api/news?id=0c34c0b3b03ebf33b5cdb2e2aa62df9dea0c5b400ba5098836973b6aae6b94b7","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"PODD","summary":"Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.","category":"company","datetime":1787079901,"headline":"Discover which S&P500 stocks are making waves on Tuesday."}, {"id":141246753,"url":"https://finnhub.io/api/news?id=fca39c0b151eec8262878ba40ac18260199ffcf7927c70595271e1c7c746f5ee","image":"https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp","source":"ChartMill","related":"PODD","summary":"Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.","category":"company","datetime":1787070901,"headline":"Stay informed with the top movers within the S&P500 index on Tuesday."}, {"id":141286142,"url":"https://finnhub.io/api/news?id=129569cd30b8396e4d3a932da1459fcb6176511123efb7ed53cd52f89d03c30d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Insulet’s second quarter was marked by strong revenue expansion but a sharp negative market reaction, as investors focused on emerging challenges in the company’s type 2 diabetes segment. While broad-based demand for Omnipod drove growth across both U.S. and international markets, CEO Ashley McEvoy acknowledged that lower-than-expected retention rates among new type 2 users weighed on results. McEvoy stated, “We should have identified the issue sooner,” signaling a more cautious approach to comm","category":"company","datetime":1786707420,"headline":"5 Must-Read Analyst Questions From Insulet’s Q2 Earnings Call"}, {"id":141205473,"url":"https://finnhub.io/api/news?id=40bf4bc8c22deb9a803efc0303d5d977c77797ed8e1884fd4dd72a44fde49e52","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the “Insiders Fund”. A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% YTD. This compares to the S&P 500’s -0.95%, 15.2%, and 9.98% […]","category":"company","datetime":1786626277,"headline":"Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier"}, {"id":141202787,"url":"https://finnhub.io/api/news?id=be604b6f0aab06f0218c44fa3c833b5aa12ee241ff46869ecda935fcdca00ca9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"PODD","summary":"Type 2 retention challenges force management to trim full-year outlook despite revenue beat.","category":"company","datetime":1786556609,"headline":"Insulet (PODD) Q2 2026 Earnings Call Transcript"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 1
positive_hits 3
recomputed_at_score true
sentiment_score_raw 0.6
source_article_count 28
discarded_article_count 18
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 3.8 5/110 76% 3.8
資金流 5.2 20/110 26% 5.2
市場環境 5.6 15/110 37.33% 5.6
催化劑 2 20/110 10% 2
風險管理 5.7 10/110 57% 5.7
技術信號 11.5 30/110 38.33% 11.5
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 3/50
ret_5d -0.1237
max_score 50
max_total 50
raw_total 3
vcp_bonus 0
vol_ratio 1.0322
ret_points 0
vol_points 2
range_ratio 0.8999
volat_points 0
day_range_pct 0.0329
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 1
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Elevated
reason risk management score >= 5/10

position

score 1.1

details

atrPct 3.8456
turnoverUsdM 230.647
liquidityPoints 0.4
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.PODD
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 121.8108

strength_details

ma_score 1
atr_score 1
rsi_score 2.5
macd_score 1
volume_score 2
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 7.7
take_profit_price 141.6018
target_multiplier 1.9
technical_strength 1.5
take_profit_percent 7.3
positionPoints 1.1
stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 7.6911
diversificationPoints 2

Calculation audit log

基本面分析總分: 3.8/5分
資金流分析總分: 5.2/20分
市場環境分析總分: 5.6/15分
催化劑分析: 2/20分
風險管理總分: 5.7/10分
技術信號分析總分: 11.5/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 92.86
atr
atr 5.0746
rule ATR / current price; lower volatility scores higher
score 4
atr_pct 3.85
cci
rule Cursor_18.24 CCI bands
level 超買或超賣風險
score 2
value -213.97
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0719
kdj
d 33.35
j -13.11
k 17.86
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 超賣或超買風險
score 2
value 38.96
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 2
trend 資金流出
value 10938245
recentSlope -357325.5
previousSlope 98720
rsi
value 24.92
sar
rule Cursor_18.24 Parabolic SAR
score 4
trend 下降
value 153.4327
position SAR喺價上
distancePct 16.27
previousTrend 下降
ma50
value 152.6988
macd
macd -3.625
trend 看跌
signal -2.5374
histogram -1.0877
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 2
value 144.3194
position <VWAP
consecutiveAbove 0
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.02
score 6
avgVolume 1712293
currentVolume 1747855
derived
ma20 144.404
ma50 152.6988
prevClose 134.68
avgVolume10 2020156
avgVolume20 1712293
changePercent -2.02
avgVolumeForScore 1712293
ma_cross
ma20 144.404
ma50 152.6988
rule Cursor_18.24 MA20/MA50 cross
cross 熊勢
score 0
prevMa20 145.128
prevMa50 153.2554
spreadPct 5.43
isVolumeBreakout false
bollinger
lower 134.3644
upper 154.4436
position 下半部
rsi_short
value 11.59
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.02

Raw calculation JSON

 
{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.1,
      "details": {
        "atrPct": 3.8455589689634,
        "turnoverUsdM": 230.64696327855003,
        "liquidityPoints": 0.4,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.PODD",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 121.8108,
      "strength_details": {
        "ma_score": 1,
        "atr_score": 1,
        "rsi_score": 2.5,
        "macd_score": 1,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 7.7,
      "take_profit_price": 141.6018,
      "target_multiplier": 1.9,
      "technical_strength": 1.5,
      "take_profit_percent": 7.3
    },
    "positionPoints": 1.1,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 7.6911179379268,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 40.8,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 37.8,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 3
  },
  "market": {
    "ma20": 144.404,
    "ma50": 152.6988,
    "close": 131.96,
    "prevClose": 134.68,
    "avgVolume20": 1712293,
    "volumeRatio": 1.02,
    "changePercent": -2.02
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 3,
    "details": {
      "ret_5d": -0.12365513348386237,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 3,
      "vcp_bonus": 0,
      "vol_ratio": 1.0322029143844211,
      "ret_points": 0,
      "vol_points": 2,
      "range_ratio": 0.8998815699180969,
      "volat_points": 0,
      "day_range_pct": 0.032850785628160954,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 1,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 40.8,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 76,
        "contribution": 3.8
      },
      {
        "raw": 5.2,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 26,
        "contribution": 5.2
      },
      {
        "raw": 5.6,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 37.33,
        "contribution": 5.6
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.7,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 57,
        "contribution": 5.7
      },
      {
        "raw": 11.5,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 38.33,
        "contribution": 11.5
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "incomplete",
  "standard110": {
    "rating": "避免",
    "result": 37.8,
    "details": [
      "基本面分析總分: 3.8/5分",
      "資金流分析總分: 5.2/20分",
      "市場環境分析總分: 5.6/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.7/10分",
      "技術信號分析總分: 11.5/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.8,
      "資金流": 5.2,
      "市場環境": 5.6,
      "情緒分析": 4,
      "技術信號": 11.5,
      "風險管理": 5.7
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "items": {
          "pbPoints": 0.2,
          "pePoints": 0.4,
          "epsPoints": 0,
          "roePoints": 0.75,
          "debtPoints": 0.5,
          "marginPoints": 0.4,
          "turnoverUsdM": 230.64696327855003,
          "volumePoints": 0.5,
          "revenuePoints": 0.75,
          "dividendPoints": 0,
          "marketCapPoints": 0.3
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 0.8,
          "obvPoints": 0.8,
          "vwapPoints": 0.8,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.PODD",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "較差",
        "items": {
          "vix": {
            "score": 0,
            "details": {
              "source": "twelvedata+fred",
              "missing": true,
              "vixClose": null
            }
          },
          "trend": {
            "score": 2.8,
            "details": {
              "qqq": {
                "ma20": 715.6679992,
                "ma50": 710.4063990999997,
                "name": "QQQ",
                "close": 714.88,
                "points": 1.4
              },
              "spy": {
                "ma20": 766.87899445,
                "ma50": 758.61640102,
                "name": "SPY",
                "close": 764.28998,
                "points": 1.4
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 3.8455589689634,
          "atrPoints": 2,
          "cciPoints": 0.8,
          "vixPoints": 0,
          "marketTrendPoints": 2.8
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 1,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.6
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 142029607,
                "url": "https://finnhub.io/api/news?id=a15ec301a31b6e7f4e0f08b004cb23dd648e2301a3e8fcc370222e3088d36e4e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "PODD",
                "summary": "Insulet Corporation (PODD) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 2:15 PM EDTCompany ParticipantsAshley McEvoy - CEO, President...",
                "category": "company",
                "datetime": 1788974829,
                "headline": "Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141951350,
                "url": "https://finnhub.io/api/news?id=28b3b3e06fe81b01c5eb52c9782efef57078576f0a8aeac8ecb4fccc662f866c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March lows as resilient economic data, strong corporate earnings, and continued AI investment improved investor sentiment despite inflation concerns, delayed rate cuts, and […]",
                "category": "company",
                "datetime": 1788872410,
                "headline": "Artisan Sold Insulet (PODD) Due to Competition Concerns"
              },
              {
                "id": 141438505,
                "url": "https://finnhub.io/api/news?id=9d42b3600ff93ffb09a10f692f5824b90d0eba371bb0c419e622ec2cff3806a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788535813,
                "headline": "Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?"
              },
              {
                "id": 141406956,
                "url": "https://finnhub.io/api/news?id=1d043a22deff0d3cc4726665b3ef514a32b8c375daaaf25689b7011a08251649",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.",
                "category": "company",
                "datetime": 1788482358,
                "headline": "Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks"
              },
              {
                "id": 141390062,
                "url": "https://finnhub.io/api/news?id=dccc316b29670c6de9edc2dcd11d9f9e8839c98c0ef6f270bdc86a8578def3be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Insulet stock has fallen sharply over the past year, yet both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market multiples currently point to the shares trading below what those models suggest, while the broader valuation score still comes through as a mixed signal rather than a clear bargain. The share price is down 57.0% over the past year, which puts recent trading well below where many investors may have entered the stock. Future adoption of Insulet's...",
                "category": "company",
                "datetime": 1788379903,
                "headline": "Insulet (PODD) Stock May Be 40% Undervalued On Fair Value Grounds"
              },
              {
                "id": 141379770,
                "url": "https://finnhub.io/api/news?id=973d3d9b65571134e6c4bde0f5b68fd5efb7f9aea2c841b60c77ad81e05f554f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Insulet (PODD) is back in focus after ongoing reminders about a securities class action lawsuit tied to alleged issues in its manufacturing controls and recent voluntary Medical Device Corrections disclosed in March and May 2026. At a share price of US$148.38, Insulet has seen short term resilience with a 7 day share price return of 3.73%. However, the 30 day share price return is down 10.26% and the 1 year total shareholder return has declined 56.98%, which points to fading momentum as...",
                "category": "company",
                "datetime": 1788361765,
                "headline": "Is Insulet (PODD) Undervalued On Lawsuit And Device Correction Risks?"
              },
              {
                "id": 141328903,
                "url": "https://finnhub.io/api/news?id=5723a8874efaeaed2fe3e923c6fabea9394b7aba4751e2b8b3d56ac1bfe82abc",
                "image": "https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp",
                "source": "ChartMill",
                "related": "PODD",
                "summary": "Insulet Corp (PODD) fits the affordable growth screen: strong EPS and revenue growth, reasonable valuation, and overall solid profitability.",
                "category": "company",
                "datetime": 1787824858,
                "headline": "Insulet (NASDAQ:PODD): Growth at a Reasonable Valuation"
              },
              {
                "id": 141364468,
                "url": "https://finnhub.io/api/news?id=f5f23b1f38e5783222ccb643de6fbd02540422cf97dae9f0047cc2cd7a0d4460",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Insulet's Q2 beat and stronger margins contrast with a 2026 growth reset, putting U.S. Type 2 retention at the center of its outlook.",
                "category": "company",
                "datetime": 1787668380,
                "headline": "Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?"
              }
            ],
            "raw_source": [
              {
                "id": 142029607,
                "url": "https://finnhub.io/api/news?id=a15ec301a31b6e7f4e0f08b004cb23dd648e2301a3e8fcc370222e3088d36e4e",
                "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
                "source": "SeekingAlpha",
                "related": "PODD",
                "summary": "Insulet Corporation (PODD) Wells Fargo 21st Annual Healthcare Conference September 9, 2026 2:15 PM EDTCompany ParticipantsAshley McEvoy - CEO, President...",
                "category": "company",
                "datetime": 1788974829,
                "headline": "Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript"
              },
              {
                "id": 141951349,
                "url": "https://finnhub.io/api/news?id=a5e82ee6c3cf64f27ddd444f5e9a43dba1000c87210d229028d562806bcf0ee3",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "PODD's Omnipod 5 adoption, product expansion and raised international growth outlook support its growth prospects despite competitive and cost pressures.",
                "category": "company",
                "datetime": 1788873840,
                "headline": "Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?"
              },
              {
                "id": 141951350,
                "url": "https://finnhub.io/api/news?id=28b3b3e06fe81b01c5eb52c9782efef57078576f0a8aeac8ecb4fccc662f866c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Artisan Partners, an investment management company, released its second-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. The letter can be downloaded here. Global equities rebounded sharply in Q2 2026, recovering from March lows as resilient economic data, strong corporate earnings, and continued AI investment improved investor sentiment despite inflation concerns, delayed rate cuts, and […]",
                "category": "company",
                "datetime": 1788872410,
                "headline": "Artisan Sold Insulet (PODD) Due to Competition Concerns"
              },
              {
                "id": 141438505,
                "url": "https://finnhub.io/api/news?id=9d42b3600ff93ffb09a10f692f5824b90d0eba371bb0c419e622ec2cff3806a8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
                "category": "company",
                "datetime": 1788535813,
                "headline": "Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?"
              },
              {
                "id": 141434501,
                "url": "https://finnhub.io/api/news?id=f73103254be6a86525c1740bf09c42233cf10fdf09a0565d6c188026dd47ff8d",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1340690121/image_1340690121.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "PODD",
                "summary": "During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products.",
                "category": "company",
                "datetime": 1788520200,
                "headline": "Baron SMID Cap ETF Q2 2026 Portfolio Activity"
              },
              {
                "id": 141406956,
                "url": "https://finnhub.io/api/news?id=1d043a22deff0d3cc4726665b3ef514a32b8c375daaaf25689b7011a08251649",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the patient monitoring industry, including Insulet (NASDAQ:PODD) and its peers.",
                "category": "company",
                "datetime": 1788482358,
                "headline": "Unpacking Q2 Earnings: Insulet (NASDAQ:PODD) In The Context Of Other Patient Monitoring Stocks"
              },
              {
                "id": 141390062,
                "url": "https://finnhub.io/api/news?id=dccc316b29670c6de9edc2dcd11d9f9e8839c98c0ef6f270bdc86a8578def3be",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Insulet stock has fallen sharply over the past year, yet both an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market multiples currently point to the shares trading below what those models suggest, while the broader valuation score still comes through as a mixed signal rather than a clear bargain. The share price is down 57.0% over the past year, which puts recent trading well below where many investors may have entered the stock. Future adoption of Insulet's...",
                "category": "company",
                "datetime": 1788379903,
                "headline": "Insulet (PODD) Stock May Be 40% Undervalued On Fair Value Grounds"
              },
              {
                "id": 141379770,
                "url": "https://finnhub.io/api/news?id=973d3d9b65571134e6c4bde0f5b68fd5efb7f9aea2c841b60c77ad81e05f554f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Insulet (PODD) is back in focus after ongoing reminders about a securities class action lawsuit tied to alleged issues in its manufacturing controls and recent voluntary Medical Device Corrections disclosed in March and May 2026. At a share price of US$148.38, Insulet has seen short term resilience with a 7 day share price return of 3.73%. However, the 30 day share price return is down 10.26% and the 1 year total shareholder return has declined 56.98%, which points to fading momentum as...",
                "category": "company",
                "datetime": 1788361765,
                "headline": "Is Insulet (PODD) Undervalued On Lawsuit And Device Correction Risks?"
              },
              {
                "id": 141370033,
                "url": "https://finnhub.io/api/news?id=381f81ad45688e1542cb11cc990ba4fa7c875e6d273eb58c2defbcb634c09e82",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "The diabetes tech firm is preparing for the launch of new devices, including a tubeless insulin pump and a fully closed loop automated insulin delivery system.",
                "category": "company",
                "datetime": 1788266868,
                "headline": "MiniMed submits new patch pump for FDA clearance"
              },
              {
                "id": 141355523,
                "url": "https://finnhub.io/api/news?id=66cd2776f7c30a964722094b09bd6a18e34943fce0381882ba1635f3c58fe405",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "PODD",
                "summary": "Curious about the top performers within the S&P500 index in the middle of the day on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.",
                "category": "company",
                "datetime": 1788194101,
                "headline": "Uncover the latest developments among S&P500 stocks in today's session."
              },
              {
                "id": 141344225,
                "url": "https://finnhub.io/api/news?id=ce6367c3e91ba904d0bcc3077660dfca1e037faf6438e4d3385f6a8c0b54f734",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2163867989/image_2163867989.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "PODD",
                "summary": "Insulet Corporation delivered strong Q2 2026 results with 23.5% revenue growth, strong customer additions, and solid profitability. Click for more on PODD.",
                "category": "company",
                "datetime": 1788003000,
                "headline": "Insulet Corporation: Strong Growth Meets A New Execution Problem"
              },
              {
                "id": 141328903,
                "url": "https://finnhub.io/api/news?id=5723a8874efaeaed2fe3e923c6fabea9394b7aba4751e2b8b3d56ac1bfe82abc",
                "image": "https://www.chartmill.com/images/uploads/Affordable_Growth_500_264px_webp_add6a3aa59.webp",
                "source": "ChartMill",
                "related": "PODD",
                "summary": "Insulet Corp (PODD) fits the affordable growth screen: strong EPS and revenue growth, reasonable valuation, and overall solid profitability.",
                "category": "company",
                "datetime": 1787824858,
                "headline": "Insulet (NASDAQ:PODD): Growth at a Reasonable Valuation"
              },
              {
                "id": 141337053,
                "url": "https://finnhub.io/api/news?id=c3c6d6b76c788113efddd79bd3fc98e7ad59df9c98e3fbb9fd6a878afa997360",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Bloomberg Indices announced the following changes to the Bloomberg 500 (B500) Index, effective prior to the open of trading on Thursday, September 10, 2026, to coincide with the September reconstitution of the index. The B500 contains 500 of the most highly capitalized US companies, weighted by float-adjusted market capitalization, representing more than USD 60 trillion in aggregate market capitalization.",
                "category": "company",
                "datetime": 1787779980,
                "headline": "Bloomberg 500 (B500) Index Adds Ten Securities Following September Reconstitution"
              },
              {
                "id": 141365784,
                "url": "https://finnhub.io/api/news?id=63fa02f189a6a151a9d95ebf513ea0ac8c3a117aa4e14aba4714ca4ff37a5f41",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Opportunities include AI-enabled adherence platforms, connected inhalers, injectors and smart packaging, telehealth and home-care integration, chronic disease support, and pharmacy-led services in underserved and Asia-Pacific markets. Medication Adherence Market Medication Adherence Market Dublin, Aug. 26, 2026 (GLOBE NEWSWIRE) -- The \"Medication Adherence Market by Type of Solution, Type of Product, Route of Administration, Therapeutic Area, End-user, and Key Geographical Regions- Trends and Fo",
                "category": "company",
                "datetime": 1787749200,
                "headline": "Medication Adherence Global Market Report 2026-2035: Profiles Medtronic, Roche, Insulet, Ypsomed, and 13 Other Key Players"
              },
              {
                "id": 141365785,
                "url": "https://finnhub.io/api/news?id=66070406c6a83f5814842e5f8f6ba4b97144f78ffea528efad6ddc579aaa15db",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "ACTON, Mass., August 26, 2026--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the Wells Fargo 21st Annual Healthcare Conference in Boston on Wednesday, September 9, 2026, at 2:15 p.m. (Eastern Time).",
                "category": "company",
                "datetime": 1787745600,
                "headline": "Insulet to Participate in Wells Fargo 21st Annual Healthcare Conference"
              },
              {
                "id": 141323906,
                "url": "https://finnhub.io/api/news?id=d51cae098bce93cf8ef7e16d66ce95996ebfd0ed923bffa3c37acb05dd0b23af",
                "image": "https://cdn.benzinga.com/files/images/story/2026/08/26/Abbott-Laboratories.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "PODD",
                "summary": "The FDA authorized Abbott&#39;s Libre Duo 10 Day, the first wearable tracking both glucose and ketones continuously for diabetes patients.",
                "category": "company",
                "datetime": 1787736992,
                "headline": "FDA Approves Abbott's First Wearable Device for Dual Ketone and Glucose Tracking"
              },
              {
                "id": 141365786,
                "url": "https://finnhub.io/api/news?id=6a5c27160372ef6f66df58924ebb451e6aa8dd85e3ec70146b96cddadab250ef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Insulet has considerably underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.",
                "category": "company",
                "datetime": 1787670731,
                "headline": "Is Wall Street Bullish or Bearish on Insulet Stock?"
              },
              {
                "id": 141364468,
                "url": "https://finnhub.io/api/news?id=f5f23b1f38e5783222ccb643de6fbd02540422cf97dae9f0047cc2cd7a0d4460",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Insulet's Q2 beat and stronger margins contrast with a 2026 growth reset, putting U.S. Type 2 retention at the center of its outlook.",
                "category": "company",
                "datetime": 1787668380,
                "headline": "Can PODD Sustain Growth After Its 2026 Guidance Reset and Q2 Beat?"
              },
              {
                "id": 141314075,
                "url": "https://finnhub.io/api/news?id=cffee9de1f9c3c33dbc7f50b1cfc92908d0a7791b14fc63ba2cec5a04d3d6cb8",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1285071364/image_1285071364.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "PODD",
                "summary": "Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.",
                "category": "company",
                "datetime": 1787613074,
                "headline": "The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products"
              },
              {
                "id": 141365788,
                "url": "https://finnhub.io/api/news?id=ce0ca9ce7f2580191193eec24899a44fe7beb18d5f4486a7b8029f443eac4d1c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "McEvoy invested $162,217 at a weighted average price of $147.47, bringing total beneficial ownership to 23,735 shares valued at $3.52 million.",
                "category": "company",
                "datetime": 1787581981,
                "headline": "Insulet CEO Ashley McEvoy Buys $160,000 in Shares After 55% Stock Decline. What Is This Telling Investors?"
              },
              {
                "id": 141308288,
                "url": "https://finnhub.io/api/news?id=e9386091a547b5c5ac5664a5b9868042b9c5f651b4bfd68eef3b900e2c40acb2",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "PODD",
                "summary": "Get insights into the top gainers and losers in the S&P500 index of Monday's pre-market session.",
                "category": "company",
                "datetime": 1787574900,
                "headline": "These S&P500 stocks are moving in today's pre-market session"
              },
              {
                "id": 141312732,
                "url": "https://finnhub.io/api/news?id=7d6c65ba66aba3343a9dc3597fee531404625af1f1cbb6ea5cb0fd4ea70557b6",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/insider_trade_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "PODD",
                "summary": "Disclosed in the latest SEC filing, a significant insider purchase on August 24, involves Ashley McEvoy, President and CEO at Insulet (NASDAQ:PODD).\nWhat Happened: McEvoy made a significant move by purchasing 1,100",
                "category": "company",
                "datetime": 1787569233,
                "headline": "President and CEO Of Insulet Purchased $162K In Stock"
              },
              {
                "id": 141286149,
                "url": "https://finnhub.io/api/news?id=d71a5e7c6aef10990f071b8cdbd16a963deff81815e0488e9ba2690edc71ef1f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Large trillion-dollar companies are tightening their grip on the market, often by acquiring smaller rivals. This trend will likely pick up with new regulatory leadership, but a few mid-sized businesses will continue prospering by anchoring themselves in unique market segments.",
                "category": "company",
                "datetime": 1787319347,
                "headline": "3 Mid-Cap Stocks with Competitive Advantages"
              },
              {
                "id": 141247855,
                "url": "https://finnhub.io/api/news?id=0c34c0b3b03ebf33b5cdb2e2aa62df9dea0c5b400ba5098836973b6aae6b94b7",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "PODD",
                "summary": "Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session.",
                "category": "company",
                "datetime": 1787079901,
                "headline": "Discover which S&P500 stocks are making waves on Tuesday."
              },
              {
                "id": 141246753,
                "url": "https://finnhub.io/api/news?id=fca39c0b151eec8262878ba40ac18260199ffcf7927c70595271e1c7c746f5ee",
                "image": "https://www.chartmill.com/images/uploads/CM_Top_Movers_Small_free_2b4ff2fc22.webp",
                "source": "ChartMill",
                "related": "PODD",
                "summary": "Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.",
                "category": "company",
                "datetime": 1787070901,
                "headline": "Stay informed with the top movers within the S&P500 index on Tuesday."
              },
              {
                "id": 141286142,
                "url": "https://finnhub.io/api/news?id=129569cd30b8396e4d3a932da1459fcb6176511123efb7ed53cd52f89d03c30d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Insulet’s second quarter was marked by strong revenue expansion but a sharp negative market reaction, as investors focused on emerging challenges in the company’s type 2 diabetes segment. While broad-based demand for Omnipod drove growth across both U.S. and international markets, CEO Ashley McEvoy acknowledged that lower-than-expected retention rates among new type 2 users weighed on results. McEvoy stated, “We should have identified the issue sooner,” signaling a more cautious approach to comm",
                "category": "company",
                "datetime": 1786707420,
                "headline": "5 Must-Read Analyst Questions From Insulet’s Q2 Earnings Call"
              },
              {
                "id": 141205473,
                "url": "https://finnhub.io/api/news?id=40bf4bc8c22deb9a803efc0303d5d977c77797ed8e1884fd4dd72a44fde49e52",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Alpha Wealth Funds, LLC, an investment management company, released its Q2 2026 letter for the “Insiders Fund”. A copy of the letter is available to download here. The Fund lost 1.45% in June, while it was up 8.43% for the 2nd quarter and 0.75% YTD. This compares to the S&P 500’s -0.95%, 15.2%, and 9.98% […]",
                "category": "company",
                "datetime": 1786626277,
                "headline": "Insulet Corporation’s (PODD) Wearable Pod Tech Finds New Frontier"
              },
              {
                "id": 141202787,
                "url": "https://finnhub.io/api/news?id=be604b6f0aab06f0218c44fa3c833b5aa12ee241ff46869ecda935fcdca00ca9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "PODD",
                "summary": "Type 2 retention challenges force management to trim full-year outlook despite revenue beat.",
                "category": "company",
                "datetime": 1786556609,
                "headline": "Insulet (PODD) Q2 2026 Earnings Call Transcript"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 1,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.6,
            "source_article_count": 28,
            "discarded_article_count": 18
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 11.5,
        "grade": "較差",
        "items": {
          "bbPoints": 1.8,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.8,
          "macdPoints": 0.8,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.8,
            "vcp_reason": "波幅收縮(34.6%→13.2%)；跌縮量(近10日3日)；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 3,
              "vol_ref": 1863216.6666666667,
              "down_days": 6,
              "vcp_ready": false,
              "above_ma50": false,
              "avg_vol_10": 1979190,
              "avg_vol_20": 1693325,
              "avg_vol_30": 1863216.6666666667,
              "range_pct_10": 0.13178234830385346,
              "range_pct_20": 0.15959380421386732,
              "range_pct_30": 0.346392820067231,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": false,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 1.0622436109595412,
              "dist_to_20d_high": 0.14957781787716684,
              "down_shrink_days": 3,
              "breakout_level_20d": 155.17,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.38044191642966496
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 0.8,
          "volumeWeight": 2,
          "maCrossPoints": 0,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.1,
            "details": {
              "atrPct": 3.8455589689634,
              "turnoverUsdM": 230.64696327855003,
              "liquidityPoints": 0.4,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.PODD",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 121.8108,
            "strength_details": {
              "ma_score": 1,
              "atr_score": 1,
              "rsi_score": 2.5,
              "macd_score": 1,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 7.7,
            "take_profit_price": 141.6018,
            "target_multiplier": 1.9,
            "technical_strength": 1.5,
            "take_profit_percent": 7.3
          },
          "positionPoints": 1.1,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 7.6911179379268,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [
    {
      "code": "VIX_MISSING",
      "symbol": "US.PODD",
      "message": "VIX market context is required for market environment scoring",
      "missing": [
        "VIX"
      ],
      "provider": "scoring"
    }
  ],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": false,
    "missingFields": [
      "VIX"
    ],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 5.0746,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 3.85
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "超買或超賣風險",
      "score": 2,
      "value": -213.97
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0719
    },
    "kdj": {
      "d": 33.35,
      "j": -13.11,
      "k": 17.86,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "超賣或超買風險",
      "score": 2,
      "value": 38.96
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 10938245,
      "recentSlope": -357325.5,
      "previousSlope": 98720
    },
    "rsi": 24.92,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 153.4327,
      "position": "SAR喺價上",
      "distancePct": 16.27,
      "previousTrend": "下降"
    },
    "ma50": 152.6988,
    "macd": {
      "macd": -3.625045870237841,
      "trend": "看跌",
      "signal": -2.5373518773709343,
      "histogram": -1.0876939928669067
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 2,
      "value": 144.3194,
      "position": "<VWAP",
      "consecutiveAbove": 0
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.02,
      "score": 6,
      "avgVolume": 1712293,
      "currentVolume": 1747855
    },
    "derived": {
      "ma20": 144.404,
      "ma50": 152.6988,
      "prevClose": 134.68,
      "avgVolume10": 2020156,
      "avgVolume20": 1712293,
      "changePercent": -2.02,
      "avgVolumeForScore": 1712293
    },
    "ma_cross": {
      "ma20": 144.404,
      "ma50": 152.6988,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "熊勢",
      "score": 0,
      "prevMa20": 145.128,
      "prevMa50": 153.2554,
      "spreadPct": 5.43,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 134.3644,
      "upper": 154.4436,
      "position": "下半部"
    },
    "rsi_short": 11.59,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.02
    }
  }
}

Raw metrics JSON

 
{
  "close": 131.96,
  "volume": 1747855,
  "changePercent": -2.02
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.